Gene · 80339
Papers3,957
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,957
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lower Frequency of PNPLA3 Polymorphism in West African Populations and Divergent Associations With Hepatocellular Carcinoma. | Gastro Hep Adv | 2025 | 40487275 | PubTator, text mining | PubMed |
| Deep Learning Reveals Liver MRI Features Associated With PNPLA3 I148M in Steatotic Liver Disease. | Liver Int | 2025 | 40478199 | PubTator, text mining | PubMed |
| Patatin-like phospholipase domain-containing 3 (PNPLA3) variants rs 738408 and rs 738409 single nucleotide polymorphism as predictor of metabolic associated fatty liver disease and its progression. | Pak J Med Sci | 2025 | 40469136 | PubTator, text mining | PubMed |
| A comprehensive evaluation of candidate genetic polymorphisms in a large histologically characterized MASLD cohort using a novel framework. | Hepatol Commun | 2025 | 40434633 | PubTator, text mining | PubMed |
| VLDL lipidomics reveals hepatocellular lipidome changes in metabolic dysfunction-associated steatotic liver disease. | Hepatol Commun | 2025 | 40408305 | PubTator, text mining | PubMed |
| Genome-wide enhancer-gene regulatory maps of liver reveal novel regulatory mechanisms underlying NAFLD pathogenesis. | BMC Genomics | 2025 | 40375105 | PubTator, text mining | PubMed |
| High inherited risk predicts age-associated increases in fibrosis in patients with MASLD. | J Hepatol | 2025 | 40334848 | PubTator, text mining | PubMed |
| Identification of NUV-244 as a PNPLA3 I148M degrading small molecule. | iScience | 2025 | 40322074 | PubTator, text mining | PubMed |
| Revealing propionate metabolism-related genes in glioblastoma and investigating their underlying mechanisms. | Front Oncol | 2025 | 40313243 | PubTator, text mining | PubMed |
| Liver lipid droplet cholesterol content is a key determinant of metabolic dysfunction-associated steatohepatitis. | Proc Natl Acad Sci U S A | 2025 | 40310463 | PubTator, text mining | PubMed |
| Widespread recessive effects on common diseases in a cohort of 44,000 British Pakistanis and Bangladeshis with high autozygosity. | Am J Hum Genet | 2025 | 40306283 | PubTator, text mining | PubMed |
| PNPLA3 Inhibition and Cardiometabolic Risk: Reassessing Dyslipidemia and Atherosclerotic Cardiovascular Disease Concerns. | Gastroenterology | 2025 | 40286941 | PubTator, text mining | PubMed |
| Genetic Variations in GCKR and PNPLA3 Regulate Metabolic Balance Across the Liver. | Diabetes | 2025 | 40272879 | PubTator, text mining | PubMed |
| A Relative Measurement of Oxidative Stress in NAFLD Through Cyclic Voltammetry Method for Clinical Translation. | Gastroenterol Res Pract | 2025 | 40270767 | PubTator, text mining | PubMed |
| A novel human hepatocyte cell line to study PNPLA3-associated steatotic liver disease. | Am J Physiol Gastrointest Liver Physiol | 2025 | 40266007 | PubTator, text mining | PubMed |
| Genetic variants associated with metabolic dysfunction-associated fatty liver diseases in a Korean population. | Eur J Med Res | 2025 | 40264238 | PubTator, text mining | PubMed |
| Gene-based therapies for steatotic liver disease. | Mol Ther | 2025 | 40254880 | PubTator, text mining | PubMed |
| PNPLA3 Polymorphism Is Inversely Correlated with Aortic Stiffness in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease Without Fibrosis. | Int J Mol Sci | 2025 | 40244110 | PubTator, text mining | PubMed |
| [Cardiometabolic and genetic factors in the progression of metabolic dysfunction-associated steatotic liver disease]. | Ter Arkh | 2025 | 40237751 | PubTator, text mining | PubMed |
| Experimental Models to Investigate PNPLA3 in Liver Steatosis. | Liver Int | 2025 | 40231787 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80339/papers?page=14